Retrospective Descriptive Analysis of Metformin with Atezolizumab in Advanced Non-Small Cell Lung Cancer in The OAK Trial

被引：10
|
作者：
Pietras, R. [1 ,2 ]
Xu, H. [3 ]
Hu, X. [3 ]
Matheny, C. [3 ]
Sandler, A. [3 ]
Patel, M. [4 ]
机构：
[1] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
[2] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Univ Minnesota, Hematol Oncol Transplant, Minneapolis, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
metformin; atezolizumab; NSCLC;
D O I：
10.1016/j.jtho.2018.08.748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-33
引用
收藏
页码：S538 / S539
页数：2
相关论文
共 50 条
  • [31] The Addition of Atezolizumab to Chemotherapy in Non-Small Cell Lung Cancer: A Trial-Based Review and Meta-Analysis
    Fitri, Nadya Keumala
    Nainggolan, Bahagia Willibrordus Maria
    Firsty, Naufal Nandita
    Pradana, Andika
    Sari, Dina Keumala
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (01) : 72 - 80
  • [32] Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer
    Wong, Pui Yee
    How, Soon Hin
    Ismail, Irnani
    Hassan, Radhiana
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 471 - 474
  • [33] Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer
    Eze, Chukwuka
    Belka, Claus
    Manapov, Farkhad
    JAMA ONCOLOGY, 2021, 7 (09) : 1341 - 1342
  • [34] Management of locally advanced non-small cell lung cancer (NSCLC) at a community hospital: A retrospective analysis
    Spranklin, Laura Jane
    Heflin, Jon Willis
    Calvo, Alejandro R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Efficacy of Osimertinib in Patients of Advanced Non-Small Cell Lung Cancer with Brain Metastasis: A Retrospective Analysis
    Zhang, J.
    Chen, L.
    Ye, M.
    Li, H.
    Zhou, C.
    Pan, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S911 - S912
  • [36] A retrospective analysis of apatinib in advanced non-small cell lung cancer patients refractory to chemotherapy.
    Xu, Jianping
    Liu, Xiaoyan
    Yang, Sheng
    Zhang, Xiangru
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Platania, Marco
    Agustoni, Francesco
    Formisano, Barbara
    Vitali, Milena
    Ducceschi, Monika
    Pietrantonio, Filippo
    Zilembo, Nicoletta
    Gelsomino, Francesco
    Pusceddu, Sara
    Buzzoni, Roberto
    TARGETED ONCOLOGY, 2011, 6 (03) : 181 - 186
  • [38] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Marco Platania
    Francesco Agustoni
    Barbara Formisano
    Milena Vitali
    Monika Ducceschi
    Filippo Pietrantonio
    Nicoletta Zilembo
    Francesco Gelsomino
    Sara Pusceddu
    Roberto Buzzoni
    Targeted Oncology, 2011, 6 : 181 - 186
  • [39] Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease
    Yamaguchi, Teppei
    Shimizu, Junichi
    Shigematsu, Fumie
    Watanabe, Naohiro
    Hasegawa, Takaaki
    Horio, Yoshitsugu
    Inaba, Yoshitaka
    Fujiwara, Yutaka
    JOURNAL OF THORACIC DISEASE, 2024, 16 (05) : 3371 - 3380
  • [40] The treatment of advanced non-small cell lung cancer
    Spiro, SG
    Silvestri, GA
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 287 - 291
12345